Advised on Purchase of Company

Healthcare

Biogroup

The leading player in medical lab testing in France with more than 670 labs France

Acquired Majority Control of Business Operations

Laborizon

The leading player in medical lab testing in Western France with 105 labs France

Biogroup Acquired Majority Control of Business Operations Laborizon

IMAP France advised BIOGROUP on its acquisition of Laborizon Group.  Majority-owned by biologists and supported by its management and BPIFrance for the past 4 years, Laborizon Group is leader in medical lab testing in Western France. Operating 105 laboratories in Centre-Val de Loire, Brittany, Pays de la Loire and Ile-de-France, it generated a pro-forma revenue of over €160 million in 2019. Since 2016, Laborizon has doubled in size thanks to the completion of 15+ acquisitions.

 

BIOGROUP, which is majority-owned by Doctor Stéphane Eimer, operates over 670 labs located throughout France. The Group is the leading player in medical lab testing in France, with a pro-forma revenue of €880 million in 2019. The Group employs over 6,600 people, of which 750 are biologists.

 

The IMAP France (Degroof Petercam) team, led by Cyril Kammoun, acted as exclusive financial advisor to BIOGROUP. Since January 2020, this is the 5th transaction in the medical lab testing industry for the team, which has established itself as the leading player in M&A advisory and financing in this sector.

 

Dr. Stéphane Eimer, Chairman of BIOGROUP, declared "Laborizon is BIOGROUP's largest acquisition to date and an important step in the group’s development. BIOGROUP is pleased to integrate Laborizon and thus, further develop in Western France. As far as I am concerned, I am looking forward to working with the Laborizon teams with whom I have developed high quality human relationships over the years. The partnership with Laborizon's biologists will enable BIOGROUP to pursue the remarkable development achieved by Laborizon over the last few years."

 

BIOGROUP started out as a biological lab founded by Biologist, Dr. Stéphane Eimer and is unique in that it is the only biologic company in France with an individual controlling shareholder. The brand is also associated with quality, high standards and an entrepreneurial culture. BIOGROUP was a regional leader in the sector in the east of France and looking to play a larger role across the country and ultimately, become the market leader.

 

SEE DEAL BRIEF 

Click here to read the article - BIOGROUP - Building a Nationwide Laboratory Testin Group in France